+987.9%
MRNA vs VCLT
-3.2%
+991.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VCLT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +1.0% | +12.1% | +7.2% |
| 7D | +20.6% | +0.4% | +20.2% | +18.3% |
| 30D | +27.1% | +3.9% | +23.2% | -2.9% |
| 3M | +353.4% | -1.9% | +355.3% | +414.7% |
| 6M | +446.3% | -2.6% | +448.9% | +539.4% |
| YTD | +776.2% | -3.1% | +779.3% | +948.4% |
| 1Y | +987.9% | -3.6% | +991.5% | +1,226.4% |
| All | +987.9% | -3.2% | +991.2% | +1,226.4% |
Cumulative growth
Daily Returns
Daily percentage return beside VCLT.
Daily Out/Under-Performance
Portfolio return minus VCLT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VCLT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VCLT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling